CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax
Cell Reports · 2023-09 · 42 (9) · 113084
DOI: 10.1016/j.celrep.2023.113084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-09. Verfasst von Mathieu Neault und 20 weiteren Autor:innen. Beteiligte Einrichtung: Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, QC, Canada; Département de Microbiologie, Infectiologie et Immunol…. Hauptthemen laut MEDLINE: Leukemia, Megakaryoblastic, Acute. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Cancer Society, Cancer Research Society, Canada Research Chairs.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, QC, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, Canada.
- Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, QC, Canada.
- Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, QC, Canada; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC, Canada.
- Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
- Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
- St. Jude Children's Research Hospital, Memphis, TN, USA.
Förderung
- Canadian Cancer Society
- Cancer Research Society
- Canada Research Chairs
- Fondation de l’Hôpital Maisonneuve-Rosemont
- Hydro-Québec
- Cole Foundation
- Fonds de Recherche du Québec - Santé
- Canadian Institutes of Health Research
Zitieren
APA
Neault, M., Lebert-Ghali, C. É., Fournier, M., Capdevielle, C., Garfinkle, E. A. R., Obermayer, A., Cotton, A., Boulay, K., Sawchyn, C., St-Amand, S., Nguyen, K. H., Assaf, B., Mercier, F. E., Delisle, J. S., Drobetsky, E. A., Hulea, L., Shaw, T. I., Zuber, J., Gruber, T. A., …, & Mallette, F. A. (2023). CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax. Cell Reports, 42(9), 113084. https://doi.org/10.1016/j.celrep.2023.113084
Vancouver
Neault M, Lebert-Ghali CÉ, Fournier M, Capdevielle C, Garfinkle EAR, Obermayer A, et al. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax. Cell Reports. 2023;42(9):113084. doi:10.1016/j.celrep.2023.113084
BibTeX
@article{Neault2023,
author = {Neault, Mathieu and Lebert-Ghali, Charles-Étienne and Fournier, Marilaine and Capdevielle, Caroline and Garfinkle, Elizabeth A R and Obermayer, Alyssa and Cotton, Anitria and Boulay, Karine and Sawchyn, Christina and St-Amand, Sarah and Nguyen, Kamy H and Assaf, Béatrice and Mercier, François E and Delisle, Jean-Sébastien and Drobetsky, Elliot A and Hulea, Laura and Shaw, Timothy I and Zuber, Johannes and Gruber, Tanja A and Melichar, Heather J and Mallette, Frédérick A},
title = {CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {9},
pages = {113084},
doi = {10.1016/j.celrep.2023.113084}
}
EUVIMED